Education
About Us
Working with TipRanks
Follow Us
IDEAYA Biosciences (IDYA)
NASDAQ:IDYA
IDYA Stock Chart & Stats
$35.50
$0.01(0.06%)
At close: 4:00 PM EST
$35.50
$0.01(0.06%)
Day’s Range― - ―
52-Week Range$13.45 - $37.08
Previous CloseN/A
Volume96.34K
Average Volume (3M)951.12K
Market Cap
$3.11B
Enterprise Value$1.68B
Total Cash (Recent Filing)$786.89M
Total Debt (Recent Filing)$27.25M
Price to Earnings (P/E)―
Beta1.46
Next Earnings
Mar 31, 2026EPS Estimate
-0.93Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.47
Shares Outstanding87,666,405
10 Day Avg. Volume1,137,672
30 Day Avg. Volume951,119
Financial Highlights & Ratios
PEG Ratio-0.11
Price to Book (P/B)1.98
Price to Sales (P/S)299.87
P/FCF Ratio-8.35
Enterprise Value/Market Cap0.54
Enterprise Value/Revenue7.82
Enterprise Value/Gross Profit7.97
Enterprise Value/Ebitda-10.73
Forecast
1Y Price Target
$49.08Price Target Upside38.25% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering15
EPS Forecast (FY)-1.25
Revenue Forecast (FY)$216.88M
Bulls Say, Bears Say
Bulls Say
Clinical Trial SuccessThe expected progression-free survival in the Phase 3 trial is significantly higher for the treatment group compared to the control.
Pipeline DevelopmentIDYA announced IND submission for IDE574, a differentiated and potential first-in-class dual KAT6/7 inhibitor.
Stock Price PotentialThe probability of an upside move for the stock is substantially higher, estimated at around 80%.
Bears Say
Development ChallengesThe company has flagged the challenges associated with developing a potent and selective dual KAT6/7 inhibitor.
Strategic Priorities ShiftGSK had elected to discontinue their 2020 collaboration around WRNi (IDE275) and POLQ (IDE705) due to a shift in GSK's strategic priorities.
IDEAYA Biosciences News
IDYA FAQ
What was IDEAYA Biosciences’s price range in the past 12 months?
IDEAYA Biosciences lowest stock price was $13.45 and its highest was $37.08 in the past 12 months.
What is IDEAYA Biosciences’s market cap?
IDEAYA Biosciences’s market cap is $3.11B.
When is IDEAYA Biosciences’s upcoming earnings report date?
IDEAYA Biosciences’s upcoming earnings report date is Mar 31, 2026 which is in 97 days.
How were IDEAYA Biosciences’s earnings last quarter?
IDEAYA Biosciences released its earnings results on Nov 04, 2025. The company reported $1.466 earnings per share for the quarter, beating the consensus estimate of -$0.827 by $2.293.
Is IDEAYA Biosciences overvalued?
According to Wall Street analysts IDEAYA Biosciences’s price is currently Undervalued.
Does IDEAYA Biosciences pay dividends?
IDEAYA Biosciences does not currently pay dividends.
What is IDEAYA Biosciences’s EPS estimate?
IDEAYA Biosciences’s EPS estimate is -0.93.
How many shares outstanding does IDEAYA Biosciences have?
IDEAYA Biosciences has 87,666,405 shares outstanding.
What happened to IDEAYA Biosciences’s price movement after its last earnings report?
IDEAYA Biosciences reported an EPS of $1.466 in its last earnings report, beating expectations of -$0.827. Following the earnings report the stock price went down -2.806%.
Which hedge fund is a major shareholder of IDEAYA Biosciences?
Currently, no hedge funds are holding shares in IDYA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
IDEAYA Biosciences Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$49.08 (38.25% Upside)
$49.08 (38.25% Upside)
Blogger Sentiment
Bullish
IDYA Sentiment 100%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Decreased
By 404.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.2%
Last 30 Days ▼ 1.8%
Last 30 Days ▼ 1.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
38.61%
12-Months-Change
Fundamentals
Return on Equity
-14.15%
Trailing 12-Months
Asset Growth
-4.41%
Trailing 12-Months
Company Description
IDEAYA Biosciences
IDEAYA Biosciences (IDYA) is a biotechnology company focused on the discovery and development of targeted therapeutics for genetically defined cancers. The company specializes in precision medicine, leveraging its proprietary biology and drug discovery platforms to design and develop innovative treatments that aim to improve patient outcomes in oncology. IDEAYA's core products include a pipeline of investigational drugs targeting specific genetic mutations and pathways in cancer cells, with a commitment to addressing unmet medical needs in cancer treatment.
IDYA Stock 12 Month Forecast
Average Price Target
$49.08
▲(38.25% Upside)
Technical Analysis
Agios Pharma
―
Travere Therapeutics
―
Celcuity
―
Arcutis Biotherapeutics
―
Beam Therapeutics
―
Ownership Overview
0.82% Insiders
34.00% Mutual Funds
32.08% Other Institutional Investors
20.05% Public Companies and
Individual Investors